Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about TAK

Recent news which mentions TAK

< Previous 1 2 3 4 5 6 7 8 9 Next >
What's Going On With Takeda Stock On Friday?
Tickers IONS NEWS TAK
Tags Biotech IONS Large Cap
From Benzinga
Ionis Pharma Wins FDA Nod For First RNA-Targeted Therapy For Rare Genetic Swelling Disorder
Tickers BCRX CSLLY IONS KALV
Tags Biotech BCRX Large Cap
From Benzinga
Takeda Pharma Maintains Outlook Even As Vyvanse Generics Hit Sales
Tickers NEWS TAK
Tags Market News why it's moving Guidance
From Benzinga
Earnings Scheduled For July 30, 2025
Tickers ACR ACT ADP AEM
Tags MCW TTEK F
From Benzinga
Insights Ahead: Takeda Pharmaceutical's Quarterly Earnings
Tickers TAK
Tags Market News Benzinga Earnings
From Benzinga
Japanese Pharma Company Takeda Expects Limited Exposure To US-China Tariffs
Tickers NEWS TAK
Tags Health Care TAK Trading Ideas
From Benzinga
Earnings Scheduled For May 8, 2025
Tickers AAOI ABCL ABEV ABL
Tags AFRM TC NEUE
From Benzinga
UK's Health Agency Endorses Pfizer's Blood Cancer Combo Therapy As First For Untreated Hodgkin Lymphoma Patients
Tickers NEWS PFE TAK
Tags Stories That Matter Top Stories General
From Benzinga
Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan
Tickers AAPG NEWS TAK
Tags AAPG Biotech Briefs
From Benzinga
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
Tickers AMGN AZN BIIB BMY
Tags MRK Government UCBJF
From Benzinga
Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study In Patients With Type Of Blood Cancer
Tickers NEWS PTGX TAK
Tags Top Stories Stories That Matter PTGX
From Benzinga
Earnings Scheduled For January 30, 2025
Tickers AAPL ABCB ABG AJG
Tags APPF TAK EMN
From Benzinga
Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights
Tickers NBIX NEWS TAK
Tags Top Stories Stories That Matter General
From Benzinga
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch
Tickers ABT COST FOOD GIS
Tags Top Stories GIS Stories That Matter
From Benzinga
Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency
Tickers ASIA NEWS TAK
Tags Benzinga Briefs Asia
From Benzinga
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Tickers MRK NEWS RHHBY SNY
Tags Biotech SNY Briefs
From Benzinga
Keros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: Analyst
Tickers KROS NEWS TAK
Tags Stories That Matter General Analyst Ratings
From Benzinga
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
Tickers ACIU NEWS TAK
Tags TAK Trading Ideas Movers
From Benzinga
Urgency, Debate Mark COP29 As Leaders Push For Carbon Market Rules, Worry About Trump
Tickers F FAN ICLN NEWS
Tags VWAGY FAN F
From Benzinga
Preview: Takeda Pharmaceutical's Earnings
Tickers TAK
Tags Benzinga Market News TAK
From Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
Tickers ALMS BMY NEWS TAK
Tags Biotech Briefs Benzinga
From Benzinga
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
Tickers JNJ NEWS TAK
Tags Top Stories Stories That Matter General
From Benzinga
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
Tickers JNJ NEWS PTGX TAK
Tags Price Target Stories That Matter Top Stories
From Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Tickers AZN BMY ELVN NEWS
Tags Biotech Briefs Benzinga
From Benzinga
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
Tickers HKMPF HKMPY MCKPF MNKTQ
Tags Benzinga HKMPF Large Cap
From Benzinga
Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
Tickers ASND NEWS TAK
Tags News FDA ASND
From Benzinga
Why Is Japanese Drugmaker Takeda Pharmaceutical Stock Trading Higher On Wednesday?
Tickers NEWS TAK
Tags Health Care TAK Trading Ideas
From Benzinga
TAK Stock Earnings: Takeda Pharmaceutical Reported Results for Q1 2024
Tickers TAK
Tags Market News Earnings Reports NYSE:TAK
From InvestorPlace
3 Biotech Stocks to Buy on the Dip: July 2024
Tickers JAZZ PCRX TAK
Tags Stocks to Buy PCRX TAK
From InvestorPlace
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
Tickers ALMS BMY JNJ NEWS
Tags Equities Price Target Analyst Ratings
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.